Skip to main content

The Wistar Institute

|

Discussing the Mysteries of Melanoma

A Q&A with Drs. Chengyu Liang and Meenhard Herlyn on skin cancer research at The Wistar Institute, including a few questions from melanoma survivors. Melanoma is the most aggressive form of skin cancer. Work at The Wistar Institute’s Melanoma Re…
|

Spotlighting Wistar’s Cheyney University Student Scientists

Read some reflections from the Cheyney University students who participated in Wistar’s Biomedical Research Methods course during Spring 2022. Lights, lab coats, action! The click of pipettes and low murmur of voices fill the open lab space as stude…
|

Wistar’s Shark Tank Pitch Competition Goes Swimmingly

The hybrid event marked the conclusion of the Institute’s Life Science Innovation Course that provides experience in biotechnology entrepreneurship. Students enrolled in The Wistar Institute’s Life Science Innovation course entered the shark ta…
|

Wistar Receives PAsmart Grant to On-Ramp More Apprentices from Our Biomedical Education & Training Programs 

For more than 20 years, The Wistar Institute has been training community college students with relevant, much-needed skills to attain in-demand jobs in the biomedical and biotechnology fields. Since 2000, Wistar understood that biomedical lab techni…
|

Workforce Development at Wistar 

In this virtual event held by the Chamber of Commerce, Wistar’s Associate Dean of Biomedical Studies Dr. David Zuzga spoke about workforce development and the value of apprenticeship programs at the Chamber of Commerce virtual event “Finding Emergin…
|

Wistar Scientists Link Mutation to a Severe Lung Disease

Newly published research identifies a mutation associated with scarring of the lungs, revealing a useful diagnostic tool and target for gene therapy. Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease that can cause death within five years…
|

Wistar Scientists Reveal New Hypothesis in How Epstein-Barr Virus Hijacks a Host

Newly published research identifies proteins in EBV-infected cells that decreased expression of genes linked to the spread of the virus, a fresh direction for EBV research. Epstein-Barr virus is a common, long-lasting virus that affects most individ…
|

A Closer Look into Our Scientific Enterprise

Dr. Luis Montaner, Wistar’s Associate Director for Shared Resources, and Mark Drinker, Wistar’s Associate Director for Administration of the Ellen and Ronald Caplan Cancer Center, chat about core facilities that support the innovations of our Wistar…
|

Zooming in on Microscopes at Wistar

From historic machinery in one of our own investigator’s personal collection to the modern technology transforming Wistar research today, microscopes have helped Wistar scientists and researchers around the world pursue innovative investigations. A…
|

Highlighting Vaccine Research at The Wistar Institute Through the Penn-CHOP-Wistar Vaccine Symposium

From HIV to COVID-19, Wistar scientists are at the forefront of vaccine development. Read our recap of the recent Vaccine Symposium and the impactful research in progress at the Institute. This past Monday, The Wistar Institute, University of Pennsy…